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Abstract 
Background: Spinach has high antioxidants and polyphenols and showed protective effects against liver diseases in 
experimental studies. We aimed to assess the association between dietary intake of spinach and odds of nonalcoholic 
fatty liver disease (NAFLD) in a case–control study among Iranian adults.
Methods: Totally 225 newly diagnosed NAFLD patients and 450 controls, aged 20–60 years, were recruited in this 
study.  Participants’ dietary intakes were collected using a valid and reliable 168‑item semi‑quantitative food fre‑
quency questionnaire (FFQ). The logistic regression test was used for assessing the association between total, raw, and 
boiled dietary spinach with the odds of NAFLD.
Results: The mean (SD) age and BMI of participants (53% male) were 38.1 (8.8) years and 26.8 (4.3) kg/m2, respec‑
tively. In the final adjusted model for potential confounders, the odds (95% CI) of NAFLD in individuals in the 
highest tertile of daily total and raw spinach intake was [0.36 (0.19–0.71), P_trend = 0.001] and [0.47 (0.24–0.89), 
P_trend = 0.008], respectively compared with those in the lowest tertile. Furthermore, in the adjusted analyses, an 
inverse association was observed between the highest yearly intake versus no raw spinach consumption and odds 
of NAFLD [(OR 0.41; 95% CI 0.18–0.96), P for trend = 0.013]. However, there was no significant association between 
higher boiled spinach intake and odds of NAFLD.
Conclusions: The present study found an inverse association between total and raw spinach intake with the odds of 
NAFLD.
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Background
Nonalcoholic fatty liver disease (NAFLD) refers to the 
state of accumulation of fat in hepatocytes in persons 
who do not consume excessive alcohol [1]. This disease 
includes a wide range of conditions from fatty liver to 
nonalcoholic steatohepatitis (NASH), fibrosis, and cir-
rhosis [2]. The NAFLD pathogenesis is defined under the 
term “Multiple-hit theory” [1], in which several factors 
including genetic susceptibility, insulin resistance, adi-
pose hormones, gut microbiome, diet, and lifestyle can 
affect the risk of NAFLD development. For example, it is 
reported some gene variants in glutathione-S-transferase 
[3], glutamate-cysteine ligase [4], peroxisome prolifer-
ator-activated receptors (PPARs) [5], etc. are associated 
with NAFLD risk in the Iranian population.
NAFLD is associated with other metabolic abnormali-
ties, such as insulin resistance, high blood glucose level, 
dyslipidemia, central adiposity, and hypertension [6]. 
Accordingly, it is believed that NAFLD is the hepatic 
manifestation of metabolic syndrome. Some underlying 
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conditions can increase NAFLD development risk, 
including obesity, type 2 diabetes mellitus (T2DM), and 
older age [7].
The average prevalence of NAFLD among the general 
population is estimated at 25% worldwide [8]. According 
to a recent meta-analysis, middle-east and Asian popula-
tions have higher NAFLD rates than the global average 
[9]. The prevalence in Iranian adults is reported between 
20 and 50% [6] reports show a growing prevalence of 
NAFLD worldwide, attributed to the upward trend of 
adverse lifestyle changes, including unhealthy diet, sed-
entary behavior, and overweight [10].
Different aspects of diet, including dietary patterns, 
various food groups such as fruits, vegetables, and whole 
and refined grains, and nutrients like types of fatty acids 
and fructose, have been investigated with NAFLD’s risk 
[11, 12]. Also, the relationship between some single veg-
etables and chronic diseases, such as carrot and breast 
cancer [13], potato and diabetes [14], green leafy veg-
etables, and cardiovascular disease (CVD) [15], etc., have 
received particular attention, recently. In line with these 
studies, the role of spinach, as a broadleaf green, rich in 
nutrients, such as folates, vitamin A, C, and K, and min-
erals such as iron, magnesium, and manganese, and poly-
phenols, especially lutein, zeaxanthin, and β-carotene 
have been considered about the risk of NAFLD [16]. 
Plenty of interventional and experimental studies, have 
investigated spinach’s antioxidant and anti-inflamma-
tory properties [16, 17]. To the best of our knowledge, 
although the association of dietary spinach with the risk 
of NAFLD was not assessed in observational studies, but 
it is shown that moderate intake of spinach may have 
protective effects against DNA oxidation [18]. Accord-
ingly, it may be expected that spinach can reduce chronic 
disease risk, mostly related to oxidative stress. For exam-
ple, some previous studies with controversial results have 
investigated the association of spinach with the odds of 
the breast (BrCa) [19, 20] and prostate cancer [21]. Fur-
thermore, atrial stiffness [22], intrahepatic stone [23], and 
gallstone [24] are the other disease indicated that spinach 
has a protective impact against them.
A recent animal study has shown that a high spinach 
intake significantly reduces the adverse effects of a high-
fat diet on the gut microbiome, blood glucose, lipid pro-
file, and cholesterol accumulation in the liver [25]. Two 
experimental studies have also shown the anti-hyperlip-
idemic effects of spinach in rats fed high cholesterol diet 
[26] and its anti-inflammatory effects in rats with a regu-
lar diet [27].
Using common foods like spinach to improve diet qual-
ity may provide a simple and inexpensive way to reduce 
the risk of chronic diseases such as NAFLD. However, 
whether individuals receiving higher dietary spinach 
than those who did not have a different risk of develop-
ing NAFLD has not been assessed in previous studies. 
Besides, previous studies have shown that heating veg-
etables can have beneficial or detrimental effects on their 
nutritional status. Accordingly, some evidence of higher 
bioavailability and stability of active nutrients such as 
phytochemicals from cooked spinach compared to raw 
spinach [28, 29], suggesting that the two methods of con-
suming spinach may be different on the risk of liver sta-
tus. Therefore, we sought to investigate the association 
between spinach’s dietary intake, either raw, boiled, and 




The present study was conducted in the Metabolic Liver 
Disease Research Center as a referral center affiliated to 
Isfahan University of Medical Sciences with a case–con-
trol design. Participants were obtained through con-
venience sampling. Totally 225 newly diagnosed NAFLD 
patients and 450 controls, aged 20–60 years, were 
recruited in this study. NAFLD diagnosis was confirmed 
by the absence of alcohol consumption and other liver 
disease etiologies, and an ultrasonography scan of the 
liver was compatible with NAFLD (Grade II, III as a defi-
nite diagnosis). The control group was selected among 
healthy individuals based on the liver ultrasonography 
(not suffering from any hepatic steatosis stages).
Although Liver biopsy, recognized as the gold standard 
for diagnosing and staging fibrosis and inflammation, has 
significant limitations such as bleeding, sampling error, 
or interobserver variability and is not readily accepted by 
all patients. Nowadays, several noninvasive techniques, 
including biochemical and hematological tests, the scor-
ing system using a combination of clinical and laboratory 
tests, Ultrasonography-based testes, and also double-
contrast magnetic resonance (MR) imaging, MR elas-
tography, and MR spectroscopy, and Diffusion-weighted 
MR imaging are used for diagnosis of fibrosis and hepatic 
inflammation [30]. Each method has its benefits and limi-
tations. The results of laboratory and biochemical tests 
and scores are overlapping and cannot predict necroin-
flammatory activity. Despite the high accuracy of (MR) 
imaging techniques for quantifying the degree of necro-
inflammation, it is expensive and not widely available in 
clinical practice [30, 31]. Although the Ultrasonography 
test is operator-dependent and may be difficult in obese 
patients with narrow intercostal space, it is low cost, safe, 
and more accessible. A previous meta-analysis indicated 
that ultrasonography allows for reliable and accurate 
detection of the moderate-severe fatty liver compared to 
histology [32]. Ultrasound is likely the imaging technique 
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of choice for screening for fatty liver in clinical and popu-
lation settings, and we used an experienced physician for 
Ultrasonography implementation and analysis.
In the present study, patients who were referred to 
screen their probability of NAFLD by an Ultrasonogra-
phy test because of having an abnormal or slight elevation 
in liver enzymes or being at risk of metabolic syndrome 
or having metabolic syndrome, etc. were evaluated for 
study eligibility criteria and patients who willing to coop-
erate were included in the study. The inclusion criteria 
for this study are not to have a special diet (due to a par-
ticular disease or weight loss) and lack of history of renal 
and hepatic diseases (Wilson’s disease, autoimmune liver 
disease, hemochromatosis, virus infection, and alcoholic 
fatty liver), CVD, diabetes, malignancy, thyroid disorder, 
and autoimmune. Also, individuals who used potentially 
hepatotoxic or steatogenic drugs were not included in 
the current study. Participants who completed less than 
35 items of the food frequency questionnaire and those 
with under or over-reported daily energy intake (≤ 800 or 
≥ 4500  kcal/d) were excluded (8 participants) and were 
replaced.  All subjects provided written informed consent 
before the study enrollment.
Dietary assessment
Participants’ dietary intakes were collected using a valid 
and reliable 168-item semi-quantitative food frequency 
questionnaire (FFQ) [33]. The FFQ listed a set of com-
mon Iranian foods with standard serving sizes. Partici-
pants were asked to express their mean dietary intake 
during the past year by choosing one of the following cat-
egories: never or less than once a month, 3–4 times per 
month, once a week, 2–4 times per week, 5–6 times per 
week, once daily, 2–3 times per day, 4–5 times per day, 
and 6 or more times a day. Portion sizes of each food item 
were converted into grams using standard Iranian house-
hold measures [34]. Daily energy and nutrients intake for 
each individual were calculated using the United States 
Department of Agriculture’s (USDA) Food Composition 
Table (FCT) [35]. The Iranian FCT was used for some 
traditional foods that do not exist in USDA FCT [36]. 
Then the consumed foods frequencies were transformed 
into a daily intake scale. Each serving size of dietary 
spinach was computed as a cup of raw spinach (30 g) 
and a 1/2 cup of cooked-boiled spinach (90 g) consump-
tion, respectively (serving size calculated using USDA 
National Nutrient Database for Standard Reference, 
http:// www. ars. usda. gov/ ba/ bhnrc/ ndl).
Anthropometric measurements
An experienced dietician performed anthropometric 
measurements. Weight was measured via a standard 
digital Seca scale (made in Germany), with minimum 
clothes and without shoes, and recorded to the nearest 
100  g. Height was measured by a mounted non-elastic 
tape meter in a relaxed shoulder standing position with 
no shoes to the nearest 0.5 cm. Body mass index (BMI) 
was computed as weight (kg) divided by height in square 
meters  (m2).
Assessment of other variables
Information on other variables, including age, sex, mari-
tal status, socioeconomic status (SES), and smoking 
status, was collected using a standard demographic ques-
tionnaire. SES score, as an index of socioeconomic status, 
was calculated based on three variables, including family 
size (≤ 4, > 4 people), education (academic and non-aca-
demic education), and acquisition (house ownership or 
not). For each of these variables, participants were given 
a score of 1 (if their family members were ≤ 4, were aca-
demically educated, or owned a house) or given a score of 
0 (if their family members were > 4, or had non-academic 
education, or leasehold property). The total SES score 
was then computed by summing up the assigned scores 
(minimum SES score of 0 to a maximum score of 3). Par-
ticipants who had a score of 3, 2, and a sum of subjects 
with 1 and 0 were classified as high, moderate, and low 
SES, respectively.
Physical activity measurement was conducted using 
the International Physical Activity Questionnaire (IPAQ) 
through face-to-face interviews. All results of the IPAQ 
were expressed as Metabolic Equivalents per week 
(METs/week).
Statistical analysis
Statistical analysis was performed using Statistical 
Package Software for Social Science, version 21 (SPSS 
Inc., Chicago, IL, USA). The normality of the data was 
tested using Kolmogorov-Smirnov’s test and histogram 
chart. Participants’ baseline characteristics and dietary 
intakes were expressed as mean ± SD or median (25–75 
interquartile range) for quantitative variables and fre-
quency (percentages) for qualitative variables. The data 
were compared between two groups by independent 
sample t test and chi-square for continuous and cat-
egorical variables, respectively. The logistic regression 
test was used for assessing the association between 
total, raw, and boiled dietary spinach with the odds of 
NAFLD. We first conducted a univariate analysis for 
each eventually confounding variable with the NAFLD 
for choosing the potential confounders. We entered the 
logistic regression analysis variables as confounders, 
whose p-value was lower than 0.20 [37]. Age and sex 
were not different between cases and controls. Based 
on the univariate analysis, the mentioned variables 
were not associated significantly with NAFLD; they do 
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not change substantially in logistic regression results, 
so they were not adjusted in the analysis.
The analysis was adjusted for potential confounders, 
including BMI, physical activity, smoking, SES, dietary 
intake of energy, high-fat dairy, and other vegetables 
except for spinach. The odds ratio (OR) with 95% con-
fidence interval (CI) of NAFLD across tertiles of the 
total, raw, and boiled dietary spinach (gram per 1000 
Kcal of energy intake) was reported. P-values < 0.05 
were considered statistically significant. We also con-
ducted an additional analysis for testing the odds of 
NAFLD between tertiles of yearly serving size intake 
of raw or boiled spinach compared to the participants 
who do not consume raw or boiled in the last year the 
reference category. As only 35 participants (20 controls, 
15 cases) not finished total spinach, which was too low 
a sample size for the reference category, we exclude the 
total spinach for this additional analysis.
Results
The mean (SD) age and BMI of participants (53% male) 
were 38.1 (8.8) years and 26.8 (4.3) kg/m2, respectively. 
Table  1 indicates the general characteristics and dietary 
intake of cases and controls. Smoking was higher among 
NAFLD patients than in control (p value = 0.006), and 
also, smoking was higher among men than women (p 
value = 0.006, data not shown). Also, NAFLD patients had 
higher BMI(p value = 0.006), SES scores (p value = 0.043), 
and lower physical activity (p value < 0.001) than the con-
trol group. Also, the NAFLD patients had a higher die-
tary intake of calorie (p value = 0.006) and high-fat dairy 
products (p value < 0.001), whereas ate higher vegetables 
(p value = 0.001), total and raw spinach (p value = 0.001), 
Table 1 Characteristics and dietary intakes among cases and controls
P values were computed using the independent sample t test and chi square for continues and categorical variables, respectively
Cases (n = 225) Controls (n = 450) P value
Age (years) 38.6 ± 8.7 37.8 ± 8.9 0.293
Male, n (%) 125 (55.6) 233 (51.8) 0.354
BMI (kg/m2) 30.5 ± 4.0 25.0 ± 3.0 < 0.001
Smoking, n (%) 16 (7.1) 12 (2.7) 0.006
Physical activity (MET/min/week) 1119 ± 616 1590 ± 949 < 0.001
SES, n(%) 0.043
Low 65 (28.9) 158 (35.1)
Middle 104 (46.2) 206 (45.8)
High 56 (24.9) 86 (19.1)
Macro and micronutrients
Energy intake (Kcal/day) 2369 ± 621 2227 ± 645 0.006
Carbohydrate (% of energy) 55.9 ± 7.4 55.9 ± 6.5 0.917
Protein (% of energy) 13.2 ± 2.4 13.2 ± 2.2 0.941
Fat (% of energy) 30.7 ± 7.4 30.8 ± 6.5 0.927
Fiber (g/1000 Kcal) 16.7 ± 8.3 15.8 ± 6.4 0.154
Calcium (mg/1000Kcal) 528 ± 163 533 ± 153 0.723
Sodium (mg/1000Kcal) 1990 ± 1960 2040 ± 1385 0.736
Potassium (mg/1000Kcal) 1546 ± 365 1596 ± 373 0.093
Food groups
Whole grains (g/day) 64.0 (30.7–115.3) 53.8 (25.1–112.8) 0.711
High fat dairy products (g/day) 237 ± 153 118 ± 107 < 0.001
Fruits (g/day) 327 ± 227 318 ± 228 0.628
Vegetables (g/day) 262 ± 138 302 ± 148 0.001
Nuts and legume (g/day) 22.1 ± 21.1 21.2 ± 18.5 0.596
Red meat (g/day) 18.1 ± 16.2 18.9 ± 17.4 0.577
Total spinach (g/day) 1.7 (0.7–3.6) 2.3 (1.0–5.6) 0.001
Raw spinach (g/day) 0.7 (0.2–1.8) 1.0 (0.5–3.0) 0.001
Boiled spinach (g/day) 0.4 (0.1–1.5) 0.6 (0.3–1.8) 0.046
Raw spinach (serving/year) 2.5 (1.2–7.6) 9.1 (3.0–22.8) < 0.001
Boiled spinach (serving/year) 1.9 (0.6–6.3) 12.0 (6.0–36.5) 0.046
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and boiled spinach (p-value = 0.046) than controls. There 
were no significant differences between the two groups 
in age and sex distribution and dietary intakes of carbo-
hydrate, protein, fat, fiber, whole grains, fruits, nuts, and 
legumes (P > 0.05).
Table  2 shows the association between tertiles of the 
total, raw, and boiled spinach consumption (g/d) and 
odds of NAFLD. In the crude model, all three spinach 
categories in the highest compared with the lowest ter-
tile were related with lower odds of NAFLD. in the final 
adjusted model for confounding variables including BMI, 
physical activity, smoking, SES, and dietary intake of 
energy, high-fat dairy, and other vegetables (except spin-
ach), the odds ratio for NAFLD in the highest compared 
to the lowest tertile of total spinach and raw spinach 
were [(OR 0.47; 95% CI 0.24–0.89), (P for trend = 0.001)] 
and [(OR 0.36; 95% CI 0.19–0.7), (P for trend = 0.008)], 
respectively. However, based on the final adjusted model, 
the intake of boiled spinach was no significantly associ-
ated with the odds of NAFLD [(OR 0.76; 95% CI 0.42–
1.38), P for trend = 0.508)].
The association of yearly dietary serving of raw and 
boiled spinach with odds of NAFLD among tertiles of 
participants, who consumed these foods compared with 
those who had no spinach intake in the last year, was pre-
sented in Table 3. In the crude model, the odds (95% CI) 
of NAFLD in subjects in the highest tertile of raw and 
boiled spinach were 0.56 (0.33–0.95), P for trend = 0.008 
and 0.60 (0.37–0.99), P for trend = 0.072 compared with 
those who had no consumption, respectively. In the final 
model, after adjusting for potential confounders, the odds 
(95% CI) of NAFLD in individuals in the highest tertile of 
raw spinach compared with those who had no consump-
tion remained significant [(OR 0.41; 95% CI 0.18–0.96), 
(P for trend = 0.013)]. However, in the final model, the 
yearly serving intake of boiled spinach was not associated 
with the odds of NAFLD.
Discussion
In the present case–control study, we found a higher 
total and raw spinach intake, associated with a lower 
odds of NAFLD. However, there was no significant asso-
ciation between the boiled spinach intake and the odds 
of NAFLD. Also, participants in the highest category of 
raw spinach consumption compared with those with no 
intake had lower odds of NAFLD; however, the highest 
versus no boiled spinach consumption showed any sig-
nificant association with NAFLD odds.
To date, no study has examined the association of spin-
ach intake from the usual diet with NAFLD. However, 
studies with conflicting results have assessed the asso-
ciation of spinach intake with the risk of some chronic 
diseases [20, 23, 24]. A previous population-based case–
control study among American participants showed that 
Table 2 Odds ratios (ORs) and 95% confidence intervals (CIs) for NAFLD based on tertiles of dietary spinach
† Model 1: adjusted for BMI, physical activity, smoking, SES, and energy intake
‡ Model 2: Additionally adjusted for dietary intake of high fat dairy and other vegetables except of spinach
Tertiles of dietary spinach intake P-trend
T1 T2 T3
Total spinach
Median intake (g/day), per 1000 Kcal 0.35 1.09 3.67
NAFLD/control 101/150 83/150 41/150
Crude model 1.00 (Ref ) 0.80 (0.55–1.16) 0.41 (0.26–0.62) < 0.001
Model  1† 1.00 (Ref ) 0.91 (0.55–1.52) 0.33 (0.18–0.59) < 0.001
Model  2‡ 1.00 (Ref ) 1.13 (0.63–2.00) 0.36 (0.19–0.71) 0.001
Raw spinach
Median intake (g/day), per 1000 Kcal 0.12 0.49 1.92
NAFLD/control 97/149 83/151 45/150
Crude model 1.00 (Ref ) 0.81(0.56–1.18) 0.45 (0.29–0.68) < 0.001
Model  1† 1.00 (Ref ) 0.90 (0.54–1.51) 0.38 (0.22–0.68) 0.001
Model 2 ‡ 1.00 (Ref ) 1.22 (0.68–2.19) 0.47 (0.24–0.89) 0.008
Boiled spinach
Median intake(g/day), per 1000 Kcal 0.06 0.30 1.14
NAFLD/control 107/148 51/152 67/150
Crude model 1.00 (Ref ) 0.45 (0.30–0.68) 0.62 (0.42–0.91) 0.100
Model  1† 1.00 (Ref ) 0.62 (0.36–1.07) 0.67 (0.40–1.13) 0.242
Model  2‡ 1.00 (Ref ) 0.72 (0.39–1.31) 0.76 (0.42–1.38) 0.508
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individuals with a high annual intake of raw spinach had 
lower odds of breast cancer than those with no intake; 
however, the highest intake of boiled spinach versus no 
intake showed no association with breast cancer. Further-
more, consumption of a carrot and raw and cooked spin-
ach twice weekly, compared to not consuming it, showed 
46% lower odds of breast cancer [20]. Another case–con-
trol study among Korean women showed no relationship 
between higher spinach intake and breast cancer risk; 
however, they do not separate raw and cooked spinach 
analysis. The association between spinach intake and 
intrahepatic and gallbladder stones was investigated in 
two case–control studies [23, 24]. spinach consump-
tion of two times weekly or more versus less than once 
monthly among Tiwanian participants was related to 65 
and 84% lower odds of intrahepatic stone for men and 
women, respectively [23]. In contrast, a study conducted 
in Netherlands showed no association between spinach 
intake and gallstone risk [24]. A cohort study that aimed 
to assess the relationship between dietary antioxidant, 
fruit, and vegetable subclasses with the risk of prostate 
cancer indicated that a higher intake of vegetables rich 
in vitamin C includes dietary spinach along with pepper 
and broccoli negatively related to the risk of prostate can-
cer incidence [21].
Although spinach individually not assessed with 
NAFLD, is investigated with the risk of liver disease as 
a part of healthy diets such as the Mediterranean diet 
(MD) [38] or Dietary Approaches to Stop Hypertension 
(DASH) diet [39], total vegetable, or one of the main 
components of non-starchy vegetables, leafy green veg-
etables, and allium vegetables. The higher adherence 
to Mediterranean and DASH diets, which have a high 
spinach content, indicated an improvement in liver imag-
ing, liver fibrosis score and showed an inverse association 
with liver diseases and related metabolic complications 
[38, 39]. Previously, it has been reported that vegeta-
ble consumption, especially beta-carotene-rich one, is 
associated with lower visceral or liver fat content and 
improved insulin sensitivity [40, 41]. It has been pro-
posed that leafy green vegetables, mostly includes spin-
ach and lettuce, have protective effects against NAFLD 
through prevention of intrahepatic triglyceride (IHTG) 
accumulation [42], hepatic steatosis, and also maintain-
ing blood glucose, insulin, and free fatty acids in normal 
hematologic ranges [43]. Furthermore, some evidence 
supports allium vegetables’ protective effects on NAFLD 
and other related disorders such as hypertension, type 2 
diabetes, and metabolic syndrome (MetS) [44, 45].
Despite limited evidence in human research, several 
animal studies have reported the possible ameliora-
tive spinach effect on NAFLD development [25, 46]. It 
has been shown that spinach consumption significantly 
reduced the adverse effects of a high-fat diet on blood 
glucose, lipid profile, and cholesterol accumulation in the 
liver [25, 46]. Two animal studies have also observed the 
anti-hyperlipidemic effects in rats fed high cholesterol 
diet [26] and the anti-inflammatory effects of spinach, by 
reducing serum TNF alpha and beta levels, in rats with a 
regular diet [27].
Several mechanisms have been proposed to explain 
leafy greens’ protective effects, such as spinach on 
NAFLD. However, it seems that nitrate and polyphe-
nols’ contents play a crucial role in this relationship. 
Supplementing the breakfast with spinach among older 
women resulted in an increase in the plasma values of 
Table 3 Odds ratios (ORs) and 95% confidence intervals (CIs) for NAFLD according to yearly intake of raw and boiled spinach
† Model 1: adjusted for BMI, physical activity, smoking, SES, and energy intake
‡ Model 2: Additionally adjusted for dietary intake of high fat dairy and other vegetables except of spinach
Categories of spinach intake P trend
0 T1 T2 T3
Raw spinach
Median intake (serving/year) 0 6.0 13.5 39.1
NAFLD/control 34/57 55/104 84/139 52/150
Crude model 1.00 (Ref ) 0.89(0.52–1.53) 1.00 (0.60–1.65) 0.56 (0.33–0.95) 0.008
Model  1† 1.00 (Ref ) 0.66 (0.32–1.38) 0.96 (0.48–1.92) 0.35 (0.17–0.73) 0.002
Model  2‡ 1.00 (Ref ) 0.76 (0.34–1.72) 1.12 (0.51–2.44) 0.41 (0.18–0.96) 0.013
Boiled spinach
Median intake (serving/year) 0 1.3 3.2 12.0
NAFLD/control 47/67 62/113 61/135 55/135
Crude model 1.00 (Ref ) 0.83 (0.51–1.35) 0.66 (0.40–1.07) 0.60 (0.37–0.99) 0.072
Model  1† 1.00 (Ref ) 0.87 (0.44–1.72) 0.88 (0.45–1.71) 0.66 (0.34–1.30) 0.211
Model  2‡ 1.00 (Ref ) 0.72 (0.33–1.57) 0.83 (0.39–1.76) 0.69 (0.32–1.47) 0.479
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polyphenols and carotenoids, including lutein, zeaxan-
thin, and β-carotene, compared with the control group 
also higher than strawberries and red wine [47]. Poly-
phenols are an important group of bioactive ingredients 
which a lot of advantageous effects such as hypolipi-
demic, anti-inflammatory, anti-fibrotic, and insulin-sen-
sitizing properties [48]. It has also been demonstrated 
that polyphenols inhibit de novo lipogenesis via SREBP1c 
downregulation and stimulate β-oxidation in the NAFLD 
models [42]. Nitrate is another important bioactive com-
pound that estimated about 80–95% of its dietary intake 
supplied through vegetables, mainly green leafy veg-
etables like spinach [49]. Previous studies have demon-
strated that dietary nitrate has protective effects against 
inflammation and oxidative stress through its ability to 
activate AMPK via a rise in the xanthine oxidase-depend-
ent NO production, and cGMP signaling declines super-
oxide levels through NADPH oxidases [50]. Wang et  al. 
found that lower serum nitrate levels directly associate 
with aging-related liver degeneration. In contrast, dietary 
nitrate can restore the serum nitrate levels and reverse 
this process in aging mice [51]. Another animal study 
claimed that spinach nitrate intake could regulate lipid 
homeostasis, inflammatory status, and endothelial func-
tion, so it is an excellent dietary constituent for insulin 
resistance prevention [52].
Boiled spinach showed a non-significant association 
with NAFLD in the present study. Two reasons may jus-
tify it; the first is the lower consumption of boiled com-
pared to the raw spinach (about 10% in daily intake by 
the gram, and about five times by serving intake per year) 
in the present study. Second, it is previously observed 
that nitrate and total polyphenolic content and antioxi-
dant activity of some vegetables, including spinach, are 
reduced during the cooking process [53, 54].
Compared with other studies investigating spinach 
and liver disorders, our study has some advantages; we 
directly assessed the association of mere spinach intake 
independent of other vegetables with NAFLD. We also 
analyzed all types of spinach consumption (total, raw, 
and cooked). We compared NAFLD risk among partici-
pants in the highest vs. lowest intake and the highest vs. 
no spinach consumption.
Besides the advantages mentioned above, our study has 
several strengths; this study is the first study investigat-
ing the association of spinach intake as a single dietary 
component with the odds of NAFLD. Besides, dietary 
data were collected by trained interviewers in a face-to-
face interview, using a validated and reproducible 168 
item food frequency questionnaire (FFQ) [55], which 
decreases measurement bias.
We also had some limitations: firstly, the inability to 
discover the causal relationships and other concerns due 
to the study’s case–control design. Secondly, NAFLD 
diagnosis was based on ultrasonography, whereas the 
gold standard was a liver biopsy and (MR) imaging 
technique is more accurate. Of course, this issue can be 
neglected because today, due to the limitations and com-
plications of biopsy and high cost and low availability of 
(MR) imaging techniques, using noninvasive methods 
ultrasonography is reliable and applicable in clinical prac-
tice [7]. The third limitation was no matching the cases 
and controls based on three essential variables, including 
age, sex, and BMI; however, there was no significant dif-
ference for age and sex between the cases and controls, 
and these variables were adjusted in analysis. We have no 
data on pubertal status, the number of pregnancies, hor-
monal conditions of participants, genetic data, etc. So, 
regarding the adjustment of several potential confound-
ers, our study design cannot eliminate all potential con-
founding, and the effects of some residual confounding 
variables may have occurred.
Conclusions
The present study found an inverse association between 
total and raw spinach intake with the odds of NAFLD. 
However, there was no significant association between 
higher boiled spinach intake and odds of NAFLD. Spin-
ach is one of the richest sources of ingredients such as 
polyphenol and antioxidants. If its beneficial effects on 
chronic disease are approved in future studies, it could 
easily be used as a powder to enrich the nutritional values 
of homemade foods or products such as dairy or other 
foods. We suggest that our hypothesis of the association 
between dietary spinach and NAFLD odds be exam-
ined in more studies with higher design power, like large 
cohort studies and clinical trials.
Abbreviations
NAFLD: Nonalcoholic fatty liver disease; CVD: Cardiovascular disease; MetS: 
Metabolic syndrome; BrCa: Breast cancer; IHTG: Intrahepatic triglyceride; IR: 
Insulin resistance; FFQ: Food Frequency Questionnaire; SES: Socioeconomic 
status; IPAQ: International Physical Activity Questionnaire; USDA: United States 
Department of Agriculture; FCT: Food Composition Table; MD: Mediterranean 
diet; DASH: Dietary approaches to stop hypertension; BMI: Body mass index; 
SREBP1c: Sterol regulatory element‑binding transcription factor 1; AMPK: AMP‑
activated protein kinase; cGMP: Cyclic guanosine monophosphate; NADPH: 
Reduced nicotinamide adenine dinucleotide phosphate; CI: Confidence 
interval; SD: Standard deviation.
Acknowledgements
This study is related to the Project No. 1398/10117 from the Student Research 
Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran. We 
also appreciate the “Student Research Committee” and “Research & Technol‑
ogy Chancellor” at Shahid Beheshti University of Medical Sciences for their 
financial support of this study. The authors express their appreciation to all of 
the participants of this study.
Authors’ contributions
EM and FT conceptualized and designed the study. FT, HF, and AS analyzed 
and interpreted the data. EM, NN, and MA drafted the initial manuscript. 
Page 8 of 9Mokhtari et al. BMC Gastroenterol          (2021) 21:196 
P.M. and FT supervised the project. All authors read and approved the final 
manuscript.
Funding
This study was supported by a grant from the student research committee, 
Project No. [1398/10117], Shahid Beheshti University of Medical Sciences, Teh‑
ran, Iran. This grant has been awarded for data collection (costs of ultrasonog‑
raphy, questionnaire printing, etc.).
Availability of data and materials
The data analyzed in the present study are available by the corresponding 
author on a reasonable request.
Declarations
Ethics approval and consent to participate
All participants filled a written informed consent.  The ethics research commit‑
tee approved the study’s protocol of the Student Research Committee, Shahid 




The authors declare that they have no competing interests.
Author details
1 Student Research Committee, Nutrition and Endocrine Research Center, 
Research Institute for Endocrine Sciences, Shahid Beheshti University of Medi‑
cal Sciences, Tehran, Iran. 2 Nutrition and Endocrine Research Center, Research 
Institute for Endocrine Sciences, Shahid Beheshti University of Medical 
Sciences, P.O. Box: 19395‑4741, Tehran, Iran. 3 Department of Clinical Nutrition 
and Dietetics, Faculty of Nutrition and Food Technology, Shahid Beheshti 
University of Medical Sciences, Tehran, Iran. 4 Department of Nutrition, School 
of Public Health, Iran University of Medical Sciences, Tehran, Iran. 
Received: 19 September 2020   Accepted: 23 April 2021
References
 1. Buzzetti E, Pinzani M, Tsochatzis EA. The multiple‑hit pathogenesis of non‑
alcoholic fatty liver disease (NAFLD). Metab Clin Exp. 2016;65(8):1038–48.
 2. Glen J, Floros L, Day C, Pryke R. Non‑alcoholic fatty liver disease (NAFLD): 
summary of NICE guidance. BMJ. 2016;354:i4428.
 3. Hashemi M, Eskandari‑Nasab E, Fazaeli A, Bahari A, Hashemzehi N‑A, 
Shafieipour S, et al. Association of genetic polymorphisms of glutathione‑
S‑transferase genes (GSTT1, GSTM1, and GSTP1) and susceptibility to 
nonalcoholic fatty liver disease in Zahedan, Southeast Iran. DNA Cell Biol. 
2012;31(5):672–7.
 4. Hashemi M, Hoseini H, Yaghmaei P, Moazeni‑Roodi A, Bahari A, 
Hashemzehi N, et al. Association of polymorphisms in glutamate‑
cysteine ligase catalytic subunit and microsomal triglyceride transfer 
protein genes with nonalcoholic fatty liver disease. DNA Cell Biol. 
2011;30(8):569–75.
 5. Saremi L, Lotfipanah S, Mohammadi M, Hosseinzadeh H, Fathi‑Kazerooni 
M, Johari B, et al. The Pro12Ala polymorphism in the PPARγ2 gene is not 
associated with an increased risk of NAFLD in Iranian patients with type 2 
diabetes mellitus. Cell Mol Biol Lett. 2019;24(1):1–8.
 6. Amirkalali B, Poustchi H, Keyvani H, Khansari MR, Ajdarkosh H, Maadi M, 
et al. Prevalence of non‑alcoholic fatty liver disease and its predictors in 
North of Iran. Iran J Public Health. 2014;43(9):1275–83.
 7. Tsai E, Lee TP. Diagnosis and evaluation of nonalcoholic fatty liver disease/
nonalcoholic steatohepatitis, including noninvasive biomarkers and 
transient elastography. Clin Liver Dis. 2018;22(1):73–92.
 8. Cotter TG, Rinella M. Nonalcoholic fatty LD. 2020: the state of the disease. 
Gastroenterology. 2020;158(7):1851–64.
 9. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. 
Global epidemiology of nonalcoholic fatty liver disease‑meta‑analytic 
assessment of prevalence, incidence, and outcomes. Hepatology. 
2016;64(1):73–84.
 10. Hallsworth K, Adams LA. Lifestyle modification in NAFLD/NASH: facts and 
figures. JHEP Rep. 2019;1(6):468–79.
 11. Lambertz J, Weiskirchen S, Landert S, Weiskirchen R, Fructose. A bietary 
sugar in crosstalk with microbiota contributing to the development and 
progression of non‑alcoholic liver disease. Front Immunol. 2017;8:1159.
 12. Duarte SMB, Stefano JT, Vanni DS, Carrilho FJ, Oliveira CPMSD. Impact 
of current diet at the risk ofnon‑alcoholic fatty liver disease (NAFLD). J 
Arquivos de Gastroenterologia. 2019;56:431–9.
 13. Chen H, Shao F, Zhang F, Miao Q. Association between dietary 
carrot intake and breast cancer: a meta‑analysis. Medicine. 
2018;97(37):e12164‑e.
 14. Bidel Z, Teymoori F, Davari SJ, Nazarzadeh M. Potato consumption and 
risk of type 2 diabetes: a dose‑response meta‑analysis of cohort studies. 
Clin Nutr ESPEN. 2018;27:86–91.
 15. Pollock RL. The effect of green leafy and cruciferous vegetable intake on 
the incidence of cardiovascular disease: a meta‑analysis. JRSM Cardiovasc 
Dis. 2016;5:2048004016661435.
 16. Roberts JL, Moreau R. Functional properties of spinach (Spinacia oleracea 
L.) phytochemicals and bioactives. Food Funct. 2016;7(8):3337–53.
 17. Chao P‑Y, Huang M‑Y, Huang W‑D, Lin K‑HR, Chen S‑Y, Yang C‑M. Study of 
chlorophyll‑related compounds from dietary spinach in human blood. 
Notulae Botanicae Horti Agrobotanici Cluj‑Napoca. 2018;46(2):309–16.
 18. Moser B, Szekeres T, Bieglmayer C, Wagner K‑H, Mišík M, Kundi M, et al. 
Impact of spinach consumption on DNA stability in peripheral lympho‑
cytes and on biochemical blood parameters: results of a human interven‑
tion trial. Eur J Nutr. 2011;50(7):587–94.
 19. Do MH, Kim JY, Jung PJ. Fruits, vegetables, soy foods and breast cancer 
in pre‑and postmenopausal Korean women: a case–control study. Int J 
Vitamin Nutr Res. 2007;77(2):130–41.
 20. Longnecker MP, Newcomb PA, Mittendorf R, Greenberg ER, Willett 
WC. Intake of carrots, spinach, and supplements containing vitamin 
A in relation to risk of breast cancer. Cancer Epidemiol Prev Biomark. 
1997;6(11):887–92.
 21. Ambrosini GL, de Klerk NH, Fritschi L, Mackerras D, Musk B. Fruit, vegeta‑
ble, vitamin A intakes, and prostate cancer risk. Prostate Cancer Prostatic 
Dis. 2008;11(1):61–6.
 22. Jovanovski E, Bosco L, Khan K, Au‑Yeung F, Ho H, Zurbau A, et al. Effect 
of spinach, ahigh dietary nitrate source, on arterial stiffness and related 
hemodynamicmeasures: a randomized, controlled trial in healthy adults. 
Clin Nutr Res. 2015;4(3):160–7.
 23. Momiyama M, Wakai K, Oda K, Kamiya J, Ohno Y, Hamaguchi M, et al. 
Lifestyle risk factors for intrahepatic stone: findings from a case–
control study in an endemic area, Taiwan. J Gastroenterol Hepatol. 
2008;23(7pt1):1075–81.
 24. Thijs C, Knipschild P. Legumeintake and gallstone risk: results from a 
case–control study. Int J Epidemiol. 1990;19(3):660–3.
 25. Elvira‑Torales LI, Periago MJ, Gonzalez‑Barrio R, Hidalgo N, Navarro‑Gon‑
zalez I, Gomez‑Gallego C, et al. Spinach consumption ameliorates the gut 
microbiota and dislipaemia in rats with diet‑induced non‑alcoholic fatty 
liver disease (NAFLD). Food Funct. 2019;10(4):2148–60.
 26. Ko SH, Park JH, Kim SY, Lee SW, Chun SS, Park E. Antioxidant effects of 
spinach (Spinacia oleracea L.) supplementation in hyperlipidemic rats. 
Prev Nutr Food Sci. 2014;19(1):19–26.
 27. Cartford MC, Gemma C, Bickford PC. Eighteen‑month‑old Fischer 344 rats 
fed a spinach‑enriched diet show improved delay classical eyeblink con‑
ditioning and reduced expression of tumor necrosis factor alpha (TNFal‑
pha) and TNFbeta in the cerebellum. J Neurosci. 2002;22(14):5813–6.
 28. Bunea A, Andjelkovic M, Socaciu C, Bobis O, Neacsu M, Verhé R, et al. 
Total and individual carotenoids and phenolic acids content in fresh, 
refrigerated and processed spinach (Spinacia oleracea L.). Food Chem. 
2008;108(2):649–56.
 29. Rock CL, Lovalvo JL, Emenhiser C, Ruffin MT, Flatt SW, Schwartz SJ. Bio‑
availability of β‑caroteneis lower in raw than in processed carrots and 
spinach in women. J Nutr. 1998;128(5):913–6.
 30. Razek A, Khashaba M, Abdalla A, Bayomy M, Barakat T. Apparent diffusion 
coefficient value of hepatic fibrosis and inflammation in children with 
chronic hepatitis. Radiol Med. 2014;119(12):903–9.
Page 9 of 9Mokhtari et al. BMC Gastroenterol          (2021) 21:196  
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
 31. Razek AA, Abdalla A, Omran E, Fathy A, Zalata K. Diagnosis and quantifica‑
tion of hepatic fibrosis in children with diffusion weighted MR imaging. 
Eur J Radiol. 2011;78(1):129–34.
 32. Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. 
Diagnostic accuracy and reliability of ultrasonography for the detection 
of fatty liver: a meta‑analysis. Hepatology. 2011;54(3):1082–90.
 33. Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. 
Dietary patterns, insulin resistance, and prevalence of the metabolic 
syndrome in women. Am J Clin Nutr. 2007;85(3):910–8.
 34. Ghaffarpour M, Houshiar‑Rad A, Kianfar HJ. The manual for household 
measures, cooking yields factors edible portion of foods. Tehran: Nashre 
Olume Keshavarzy. 1999;7(213):42–58.
 35. Bowman SA, Friday JE, Moshfegh AJ. MyPyramid Equivalents Database, 
2.0 for USDA survey foods, 2003–2004: documentation and user guide. 
2008.
 36. Azar M, Sarkisian E. Food composition table of Iran: National Nutrition 
and Food Research Institute. Tehran: Shaheed Beheshti University; 1980.
 37. Mirmiran P, Esfandiari S, Bahadoran Z, Tohidi M, Azizi F. Dietary insulin load 
and insulin index are associated with the risk of insulin resistance: a pro‑
spective approach in Tehran lipid and glucose study. J Diabetes Metab 
Disord. 2015;15:23.
 38. Kaliora AC, Gioxari A, Kalafati IP, Diolintzi A, Kokkinos A, Dedoussis GV. 
The effectivenessof Mediterranean diet in nonalcoholic fatty liver disease 
clinical course: anintervention study. J Med Food. 2019;22(7):729–40.
 39. Hekmatdoost A, Shamsipour A, Meibodi M, Gheibizadeh N, Eslamparast 
T, Poustchi H. Adherence to the dietary approaches to stop hypertension 
(DASH) and risk of nonalcoholic fatty liver disease. Int J Food Sci Nutr. 
2016;67(8):1024–9.
 40. Takagi T, Hayashi R, Nakai Y, Okada S, Miyashita R, Yamada M, et al. 
Dietary intake ofcarotenoid‑rich vegetables reduces visceral adiposity 
in obese Japanese men—arandomized, double‑blind trial. Nutrients. 
2020;12(8):2342.
 41. van Eekelen E, Geelen A, Alssema M, Lamb HJ, de Roos A, Rosendaal FR, 
et al. Sweet snacks arepositively and fruits and vegetables are negatively 
associated with visceral orliver fat content in middle‑aged men and 
women. J Nutr. 2019;149(2):304–13.
 42. Chakravarthy MV, Waddell T, Banerjee R, Guess N. Nutrition and non‑
alcoholic fatty liver disease: current perspectives. Gastroenterol Clin. 
2020;49(1):63–94.
 43. Lim M, Kim J. Association between fruit and vegetable consumption and 
risk of metabolic syndrome determined using the Korean Genome and 
Epidemiology Study (KoGES). Eur J Nutr. 2020;59(4):1667–78.
 44. Hosseinpour‑Niazi S, Bakhshi B, Betru E, Mirmiran P, Darand M, Azizi F. 
Prospective study of total and various types of vegetables and the risk of 
metabolic syndrome among children and adolescents. World J Diabetes. 
2019;10:362–75.
 45. Emamat H, Farhadnejad H, Tangestani H, Totmaj A, Poustchi H, Hekmat‑
doost A. Associationof allium vegetables intake and non‑alcoholic fatty 
liver disease risk: a case–controlstudy. Nutr Food Sci. 2020;. https:// doi. 
org/ 10. 1108/ NFS‑ 11‑ 2019‑ 0334.
 46. Elvira‑Torales LI, Martín‑Pozuelo G, González‑Barrio R, Navarro‑González 
I, Pallarés F‑J, Santaella M, et al. Ameliorative effect of spinach on non‑
alcoholic fatty liver disease induced in rats by a high‑fat diet. Int J Mol Sci. 
2019;20(7):1662.
 47. Paiva SA, Yeum K‑J, Cao G, Prior RL, Russell RM. Postprandialplasma carot‑
enoid responses following consumption of strawberries, red wine,vitamin 
C or spinach by elderly women. J Nutr. 1998;128(12):2391–4.
 48. Lee Y, Hu S, Park YK, Lee JY. Healthbenefits of carotenoids: a role of carot‑
enoids in the prevention ofnon‑alcoholic fatty liver disease. Prev Nutr 
Food Sci. 2019;24(2):103–13.
 49. Mirmiran P, Bahadoran Z, Golzarand M, Asghari G, Azizi F. Consumption 
of nitrate containing vegetables and the risk of chronic kidney disease: 
Tehran Lipid and Glucose Study. Ren Fail. 2016;38(6):937–44.
 50. Lundberg JO, Carlström M, Weitzberg E. Metabolic effects of dietary 
nitrate in health and disease. Cell Metab. 2018;28(1):9–22.
 51. Wang H, Hu L, Li L, Wu X, Fan Z, Zhang C, et al. Inorganic nitrate allevi‑
ates the senescence‑related decline in liver function. Sci China Life Sci. 
2018;61(1):24–34.
 52. Heidari H, Kamalinejad M, Noubarani M, Rahmati M, Jafarian I, Adiban H, 
et al. Protective mechanisms of Cucumis sativus in diabetes‑related mod‑
els of oxidative stress and carbonyl stress. Bioimpacts. 2016;6(1):33–9.
 53. Gunathilake K, Ranaweera K, Rupasinghe HPV. Effectof different cook‑
ing methods on polyphenols, carotenoids and antioxidantactivities of 
selected edible leaves. Antioxidants. 2018;7(9):117.
 54. Salehzadeh H, Maleki A, Rezaee R, Shahmoradi B, Ponnet K. The nitrate 
content of fresh and cooked vegetables and their health‑related risks. 
PLoS One. 2020;15(1):e0227551‑e.
 55. Hosseini Esfahani F, Asghari G, Mirmiran P, Azizi F. Reproducibility and 
relative validity of food group intake in a Food Frequency Question‑
naire Developed for the Tehran Lipid and Glucose Study. J Epidemiol. 
2010;20(2):150–8.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in pub‑
lished maps and institutional affiliations.
